Drug delivery companies develop technologies, formulations and platforms that control how, where and when therapeutic agents are released in the body. The field focuses on improving treatment efficacy, reducing side effects and helping medicines reach their intended targets safely and efficiently.
This category includes companies working on:
Browse 119 UK drug delivery companies below.
Non-viral intracellular drug delivery for solid tumours
Vitarka Therapeutics is a preclinical biotech company developing a non-viral drug delivery platform for targeted intracellular delivery of therapeutics to solid tumours. The technology uses pore-forming proteins to transport RNAi therapies and other payloads directly into cancer cells while limiting off-target…
AI-enabled personalised dosing for drug-digital combination therapies
Closed Loop Medicine develops combination products integrating pharmaceutical therapies with AI-powered digital companions to personalise drug dosing for chronic conditions. Its platform applies pharmacometric modelling and patient response data to optimise treatment regimens. The pipeline includes co-packaged drug…
Targeted oral drug delivery platform for cancer, CNS and respiratory disease
TRX Biosciences is a biotechnology company developing a targeted oral drug delivery platform, enabling therapies to reach specific organs, cells and tissues for cancer, central nervous system, respiratory and immune system diseases. The company's technology is licensed to partner companies for use in their own drug…
Formulation development CDMO for difficult pharmaceuticals
Agility Life Sciences is a contract development and manufacturing organisation specialising in pharmaceutical formulation development. Based in Stapleford, Nottingham, the company helps biotech and pharma clients overcome solubility, stability, and bioavailability challenges across oral, ocular, intravenous,…
Clinical gamma scintigraphy for pharmaceutical formulation evaluation
Cardiff Scintigraphics is an independent contract research company specialising in gamma scintigraphy, a clinical imaging technique using radiolabelled drug formulations to visualise and quantify in vivo drug deposition in humans. Its services support pharmaceutical and medical device companies in evaluating inhaled,…
Specialist CDMO with spray drying and dosage form expertise
Upperton Pharma Solutions is a contract development and manufacturing organisation specialising in formulation development and clinical trial manufacturing for oral, nasal, pulmonary, and sterile dosage forms. The company is recognised for its expertise in pharmaceutical spray drying, a particle engineering technology…
Non-viral gene therapy platform enabling durable nuclear DNA delivery
Gramics Bio develops a gene therapy platform solving a key limitation of lipid nanoparticle delivery: enabling therapeutic DNA to reach the cell nucleus for durable expression without viral vectors. By programming specificity into synthetic DNA sequences rather than new delivery chemistries, the technology combines…
Specialist pharma acquiring and developing rare disease therapeutics
Ambrose Healthcare is a UK specialist pharmaceutical company developing treatments for rare diseases and patients in hospital and specialist care settings. The company builds its pipeline through the acquisition and licensing of late-stage clinical assets with existing human safety and efficacy data, targeting…
Oxygen-generating nanoparticles to overcome hypoxia in solid tumours
StimOxyGen is a preclinical-stage biotechnology company developing pH-responsive nanoparticle formulations to address tumour hypoxia, a major barrier to effective cancer treatment. The technology uses a biodegradable polymer coating that dissolves in the acidic tumour microenvironment, transiently generating localised…
Synthetic platform for precision delivery of biologics in tissue repair
Renovos Biologics is a biotech company developing precision delivery technologies for regenerative medicine, drawing on decades of academic research in skeletal stem cells, biomaterials and translational orthopaedic science at the University of Southampton. Its proprietary synthetic platform enables injectable,…
AI platform for drug target identification and discovery
BenevolentAI is a UK-founded biotech company that develops and applies AI and machine learning to accelerate drug discovery. Its platform integrates knowledge graphs, proprietary ontologies, and large language models to identify novel therapeutic targets and design small molecule candidates across multiple disease…
Drug-free nasal barrier spray blocking airborne viruses and allergens
Birmingham Biotech is a University of Birmingham spin-out selling NoriZite, a drug-free nasal spray that creates a structured fluid-gel barrier in the nasal cavity for up to six hours, trapping airborne viruses, allergens and particulate pollution at the point of entry. The dual-polymer matrix formulation, developed…
Bacillus spore-based vaccines, drug delivery and probiotic therapeutics developer
SporeGen is a biotechnology company working exclusively on spore-forming Bacillus bacteria to develop vaccines, drug delivery platforms and probiotic therapeutics. The company's SporeVax platform uses bacterial spores as a vaccine delivery agent, and its SPOR-COV nasal spray, developed with a commercial partner, aims…
Generic and branded prescription medicines development and supply
Northumbria Pharma is a pharmaceutical company specialising in the development, manufacture, licensing, and supply of generic and branded prescription medicines across primary and secondary care. Its portfolio spans multiple therapeutic areas including rare diseases, neurology, respiratory, and oncology supportive…
Engineered probiotic bacteria producing peptide therapeutics inside the body
Hijack Bio develops engineered probiotic bacteria designed to produce and release peptide therapeutics inside the body. The synthetic biology approach aims to reduce reliance on conventional external manufacturing and cold-chain distribution while enabling oral delivery of peptide drugs. Potential applications include…
Bispecific antibody-drug conjugates for cancer-selective precision therapy
BiVictriX Therapeutics is a biopharmaceutical company developing bispecific antibody-drug conjugates for targeted cancer treatment. Its Bi-Cygni platform recognises combinations of two tumour-associated antigens to improve cancer-cell selectivity and limit effects on healthy tissues. Its lead solid-tumour candidate,…
Programmable RNA delivery platform targeting non-hepatic tissues
Sixfold Bioscience is a biotechnology company developing a programmable RNA-based delivery platform that exploits the body's natural extracellular RNA transport pathways to direct therapeutic RNA molecules to specific non-hepatic tissues and cell types. The platform uses computationally designed chemical modifications…
Supramolecular encapsulation chemistry for controlled active delivery
Aqdot is a chemical technology company developing supramolecular systems for capturing, protecting and releasing active ingredients. Its encapsulation platform is commercially applied to odour removal and industrial formulations, while its research extends to RNA delivery systems for vaccines and cancer therapies. The…
Commercial-scale spray drying and particle engineering CDMO
Codis is a contract development and manufacturing organisation specialising in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and particle engineering. Formed through the integration of Particle Dynamics in the US and a spray drying facility in Haverhill previously operated by EuroAPI,…
High-performance specialty ingredients for pharma, biotech and agriculture
Croda is a speciality chemicals company developing and manufacturing high-performance ingredients for pharmaceutical, biotechnology, and agricultural markets. Its life sciences portfolio encompasses lipid nanoparticle delivery systems, high-purity pharmaceutical excipients, vaccine adjuvant components, and crop…